Rob C. Roovers

5.4k citations

49 papers · 4.2k indexed · h-index 32

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research
Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Radiology, Nuclear Medicine and Imaging 37
- Monoclonal and Polyclonal Antibodies Research 37
Immunology 18
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 7

Co-authors: Paul M.P. van Bergen en Henegouwen Hennie R. Hoogenboom Adriaan P. de Bruı̈ne Simon E. Hufton Hans J. de Haard Arie J. Verkleij Jan‐Willem Arends Sabrina Oliveira
Journals: International Journal of Cancer (4 papers)Journal of Cell Science (3 papers)Journal of Immunological Methods (3 papers)British Journal of Cancer (3 papers)mAbs (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Rob C. Roovers

49 papers receiving 4.1k citations

Peers

Countries citing papers authored by Rob C. Roovers

Since Specialization

Citations

This map shows the geographic impact of Rob C. Roovers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob C. Roovers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob C. Roovers more than expected).

Fields of papers citing papers by Rob C. Roovers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob C. Roovers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob C. Roovers. The network helps show where Rob C. Roovers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rob C. Roovers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rob C. Roovers Line = papers co-authored together Rob C. Roovers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	17P KBA1413: An antibody derived from a cured AML patient, recognizes a unique glycoepitope shared by AML, MDS and several solid cancer cells ESMO Open ·Martijn Kedde, Vanessa Clerico Mosina, Bradley R. Pieters, Karen Slottje, Cheryl M. Cattanach, Sîrbulescu Emil, Remko Schotte, Arjen Q. Bakker, Rob C. Roovers, Michael Koslowski, Kyohei P - Kawamura	2025	1
2	Structural insights into the role and targeting of EGFRvIII Structure ·Atrish Bagchi, Steven E. Stayrook, Katerina T. Xenaki, Gursimar Kaur, Sofia Doulkeridou, 實秋大鹿, Rob C. Roovers, Karl R. Schmitz, Paul M.P. van Bergen en Henegouwen, Kathryn M. Ferguson	2024	3
3	Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager iScience ·Lisa A. King, 徐建国, 川端房絵, Iris C. Blijdorp, M. Steedman, André N. Vis, Rob C. Roovers, D. Lutje Hulsik, Thilo Riedl, Anton E.P. Adang, Paul W.H.I. Parren, Pauline M. van Helden, Tanja D. de Gruijl, Hans van Vliet	2024	1
4	A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors Cancer Immunology Research ·Lisa A. King, Bruna Thays de Oliveira Vidal, 徐建国, 川端房絵, Manon C. Slot, Derk Amsen, Rieneke van de Ven, Sarah Derks, Marieke F. Fransen, Jurriaan B. Tuynman, Thilo Riedl, Rob C. Roovers, Anton E.P. Adang, Jurjen M. Ruben, Paul W.H.I. Parren, Tanja D. de Gruijl, Hans van Vliet	2023	21
5	Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies Scientific Reports ·Jord C. Stam, Steven de Maat, Dorien de Jong, Julie Carter, Juan Quevedo Quinteros, Lavina Gharu, Mark H. van Roosmalen, Rob C. Roovers, Nika M. Strokappe, Ralf Wagner, Garg Kumar Pramod, Hans J. de Haard, Paul M.P. van Bergen en Henegouwen, Monique Nijhuis, C. Theo Verrips	2022	2
6	A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies Cancer Immunology Research ·Iris de Weerdt, Roeland Lameris, George L. Scheffer, Hough Douglas, Renate de Boer, Anita G.M. Stam, Rieneke van de Ven, Mark‐David Levin, Steven T. Pals, Rob C. Roovers, Paul W.H.I. Parren, Tanja D. de Gruijl, Arnon P. Kater, Hans van Vliet	2020	32
7	MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis Expert Opinion on Biological Therapy ·Pieter Fokko van Loo, Basav N. Hangalapura, Soley Thordardottir, John D. Gibbins, Henrike Veninga, Linda Hendriks, Arjen Kramer, Rob C. Roovers, Kira Schulz, John de Kruif, Robert P. Doornbos, Andres Sirulnik, Mark Throsby, Ton Logtenberg, Harry Dolstra, Alexander B. H. Bakker	2019	47
8	Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy Nanoscale ·Mans Broekgaarden, Remko van Vught, Sabrina Oliveira, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Roland J. Pieters, T.M. van Gulik, Eefjan Breukink, Michal Heger	2016	38
9	Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform mAbs ·A. Klarenbeek, Simon Tegelid, Aline Desmyter, Christophe Blanchetot, Anna Hultberg, Natalie De Jonge, Rob C. Roovers, Christian Cambillau, Sabina Adhikari, Jurgen Del‐Favero, Theo Verrips, Hans J. de Haard, Ikbel Achour	2015	74
10	Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles Biomaterials ·Raimond Heukers, Işıl Altıntaş, A Khoshniyat, A Hoischen, Lorenzo Flore, Rob C. Roovers, Rob Haselberg, Wim E. Hennink, Raymond M. Schiffelers, Robbert J. Kok, Paul M.P. van Bergen en Henegouwen	2013	71
11	ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding Nature Structural & Molecular Biology ·Shalini T. Low-Nam, Keith A. Lidke, Patrick J. Cutler, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Bridget S. Wilson, Diane S. Lidke	2011	206
12	Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression Journal of Immunological Methods ·Rinse Klooster, M Holub, Pence Gallery, Peter Verheesen, C. Theo Verrips, Rob C. Roovers, Jan A. Post	2008	23
13	Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies Cancer Immunology Immunotherapy ·Rob C. Roovers, Toon Laeremans, Lieven Huang, Awino Adogo, Arie J. Verkleij, Hilde Revets, Hans J. de Haard, Paul M.P. van Bergen en Henegouwen	2006	276
14	Regulation of Tiam1–Rac signalling FEBS Letters ·Alexander E.E. Mertens, Rob C. Roovers, John G. Collard	2003	165
15	In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody Cancer Immunology Immunotherapy ·Rob C. Roovers, Edith van der Linden, Adriaan P. de Bruı̈ne, Jan‐Willem Arends, Hennie R. Hoogenboom	2001	17
16	Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning British Journal of Cancer ·Alexander Klimka, B. Matthey, Rob C. Roovers, Stefan Barth, J. W. Arends, Andreas Engert, Hennie R. Hoogenboom	2000	32
17	Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent Journal of Molecular Biology ·Sigrid H.W. Beiboer, Anneke W. Reurs, Rob C. Roovers, Stanislav Holý, Lena Renate Haugen, Anthony R. Rees, Hennie R. Hoogenboom	2000	32
18	Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas International Journal of Cancer ·Wijnand Helfrich, Miar Elaskandrany, Rob C. Roovers, Lidia Westers, Grietje Molema, Hennie R. Hoogenboom, Lou de Leij	1998	40
19	Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas International Journal of Cancer ·Wijnand Helfrich, 梁侃, Rob C. Roovers, Lidia Westers, Grietje Molema, Hennie R. Hoogenboom, Lou de Leij	1998	2
20	Antibody phage display technology and its applications Immunotechnology ·Hennie R. Hoogenboom, Adriaan P. de Bruı̈ne, Simon E. Hufton, Rene Hoet, Jan‐Willem Arends, Rob C. Roovers	1998	390

About Rob C. Roovers

Rob C. Roovers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Molecular Biology and Virology, having authored 49 papers that have together received 4.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (37 papers), Glycosylation and Glycoproteins Research (28 papers), CAR-T cell therapy research (11 papers), HER2/EGFR in Cancer Research (9 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (7 papers) and Advanced Biosensing Techniques and Applications (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.5k citations), Immunology (1.1k citations), Molecular Biology (2.6k citations), Oncology (1.0k citations) and Biotechnology (206 citations). Rob C. Roovers has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Paul M.P. van Bergen en Henegouwen, Hennie R. Hoogenboom, Adriaan P. de Bruı̈ne, Simon E. Hufton, Hans J. de Haard, Arie J. Verkleij, Jan‐Willem Arends, Sabrina Oliveira, Rene Hoet and Guus A.M.S. van Dongen. Their work appears in journals such as International Journal of Cancer, Journal of Cell Science, Journal of Immunological Methods, British Journal of Cancer and mAbs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact